All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

IBRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 83.40%

Insider Buying (Last 12 Months): $268,516.25

Insider Selling (Last 12 Months): $0.00

ImmunityBio Insider Trading History Chart

ImmunityBio Share Price & Price History

^$3.43

▼ -0.03 (-0.87%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

ImmunityBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2023	Michael D. Blaszyk	Director	Buy	71,915	$2.75	$197,766.25	71,915
6/2/2023	John Owen Brennan	Director	Buy	25,000	$2.83	$70,750.00	25,000
10/8/2021	Richard Adcock	CEO	Buy	1,930	$8.81	$17,003.30
8/23/2021	Cheryl Cohen	Director	Sell	14,801	$10.12	$149,786.12	215,418
8/20/2021	Cheryl Cohen	Director	Sell	9,976	$10.00	$99,760.00	215,418
8/17/2021	Cheryl Cohen	Director	Sell	43,398	$10.12	$439,187.76
5/24/2021	Barry J. Simon	Director	Sell	21,223	$16.02	$339,992.46	3,212,517
5/21/2021	Barry J. Simon	Director	Sell	14,990	$16.09	$241,189.10	3,212,517

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for ImmunityBio (NASDAQ:IBRX)

8.60% of ImmunityBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunityBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Armistice Capital LLC	3,476,000	$5.87M	0.1%	N/A	0.762%
11/14/2023	California State Teachers Retirement System	140,718	$0.24M	0.0%	-7.2%	0.031%
11/13/2023	Northern Trust Corp	1,152,757	$1.95M	0.0%	-0.8%	0.253%
11/13/2023	Rathbones Group PLC	73,420	$0.12M	0.0%	N/A	0.016%
11/13/2023	WINTON GROUP Ltd	15,438	$26K	0.0%	N/A	0.003%
11/13/2023	FMR LLC	14,881	$25K	0.0%	+190.0%	0.003%
11/13/2023	Kestra Advisory Services LLC	23,300	$39K	0.0%	-12.7%	0.005%
11/9/2023	Rhumbline Advisers	141,795	$0.24M	0.0%	-3.6%	0.031%
11/9/2023	Blair William & Co. IL	162,462	$0.28M	0.0%	+200.7%	0.036%
11/8/2023	Vanguard Personalized Indexing Management LLC	21,606	$37K	0.0%	N/A	0.005%
11/8/2023	Charles Schwab Investment Management Inc.	1,049,934	$1.77M	0.0%	+7.3%	0.230%
11/8/2023	New York Life Investment Management LLC	195,629	$0.33M	0.0%	-13.6%	0.043%
11/7/2023	Merit Financial Group LLC	43,800	$74K	0.0%	+84.0%	0.010%
11/7/2023	Virtus ETF Advisers LLC	34,461	$58K	0.0%	-9.0%	0.008%
11/7/2023	Barclays PLC	44,373	$75K	0.0%	-26.6%	0.010%
11/3/2023	Liberty One Investment Management LLC	47,578	$80K	0.0%	-5.9%	0.010%
11/1/2023	Stonehage Fleming Financial Services Holdings Ltd	85,000	$0.14M	0.0%	N/A	0.019%
10/30/2023	Aire Advisors LLC	14,768	$25K	0.0%	N/A	0.003%
10/18/2023	Exchange Traded Concepts LLC	58,136	$98K	0.0%	+22.3%	0.013%
10/16/2023	Traynor Capital Management Inc.	14,950	$25K	0.0%	N/A	0.003%
10/16/2023	Wealth Effects LLC	53,500	$90K	0.0%	-24.6%	0.012%
10/13/2023	SG Americas Securities LLC	33,697	$57K	0.0%	N/A	0.007%
9/21/2023	Barclays PLC	60,469	$0.17M	0.0%	+46.5%	0.013%
8/30/2023	Western Wealth Management LLC	20,795	$58K	0.0%	N/A	0.005%
8/21/2023	California State Teachers Retirement System	151,684	$0.42M	0.0%	+11.6%	0.033%
8/21/2023	Osaic Holdings Inc.	12,878	$36K	0.0%	-45.2%	0.003%
8/15/2023	Alliancebernstein L.P.	299,010	$0.83M	0.0%	+18.9%	0.066%
8/15/2023	Wells Fargo & Company MN	63,953	$0.18M	0.0%	+93.2%	0.014%
8/15/2023	Fishman Jay A Ltd. MI	162,000	$0.45M	0.1%	+44.6%	0.036%
8/15/2023	Bell & Brown Wealth Advisors LLC	20,100	$56K	0.0%	N/A	0.004%
8/15/2023	Goldman Sachs Group Inc.	273,120	$0.76M	0.0%	-22.8%	0.060%
8/14/2023	Tower Research Capital LLC TRC	13,869	$39K	0.0%	-48.7%	0.003%
8/14/2023	State Street Corp	2,777,236	$7.72M	0.0%	+4.8%	0.609%
8/14/2023	Nuveen Asset Management LLC	429,725	$1.20M	0.0%	+78.6%	0.094%
8/11/2023	Credit Suisse AG	1,016,494	$2.83M	0.0%	+14.3%	0.223%
8/11/2023	BlackRock Inc.	9,498,666	$26.41M	0.0%	+36.4%	2.082%
8/11/2023	Kestra Advisory Services LLC	26,700	$74K	0.0%	N/A	0.006%
8/11/2023	State Board of Administration of Florida Retirement System	31,297	$87K	0.0%	+37.8%	0.007%
8/11/2023	The Manufacturers Life Insurance Company	46,923	$0.13M	0.0%	+17.4%	0.010%
8/11/2023	Geode Capital Management LLC	2,730,452	$7.59M	0.0%	+40.3%	0.598%
8/11/2023	JPMorgan Chase & Co.	1,478,953	$4.11M	0.0%	-8.3%	0.324%
8/11/2023	PNC Financial Services Group Inc.	20,100	$56K	0.0%	N/A	0.004%
8/11/2023	Northern Trust Corp	1,161,699	$3.23M	0.0%	+43.1%	0.255%
8/10/2023	MetLife Investment Management LLC	58,479	$0.16M	0.0%	+246.1%	0.013%
8/10/2023	Osaic Holdings Inc.	12,878	$36K	0.0%	-45.2%	0.003%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	32,589	$91K	0.0%	+21.7%	0.007%
8/10/2023	Charles Schwab Investment Management Inc.	978,547	$2.72M	0.0%	+36.7%	0.224%
8/10/2023	Citigroup Inc.	43,514	$0.12M	0.0%	+462.9%	0.010%
8/9/2023	Swiss National Bank	284,600	$0.79M	0.0%	+9.8%	0.065%
8/9/2023	Sheets Smith Wealth Management	269,129	$0.75M	0.1%	-83.1%	0.062%
8/8/2023	Clearwater Capital Advisors LLC	394,599	$1.10M	0.1%	+24.4%	0.091%
8/7/2023	Principal Financial Group Inc.	74,054	$0.21M	0.0%	+14.3%	0.017%
8/7/2023	New York Life Investment Management LLC	226,447	$0.63M	0.0%	-13.7%	0.052%
8/4/2023	Ascent Wealth Partners LLC	10,000	$28K	0.0%	N/A	0.002%
8/4/2023	American International Group Inc.	53,064	$0.15M	0.0%	+34.3%	0.012%
8/4/2023	Liberty One Investment Management LLC	50,587	$0.14M	0.0%	+63.8%	0.012%
8/3/2023	Barclays PLC	60,469	$0.17M	0.0%	+46.5%	0.014%
8/3/2023	Bank of New York Mellon Corp	521,808	$1.45M	0.0%	+18.5%	0.120%
7/20/2023	Exchange Traded Concepts LLC	47,540	$0.13M	0.0%	N/A	0.011%
7/19/2023	Grimes & Company Inc.	10,000	$28K	0.0%	N/A	0.002%
7/18/2023	Wealth Effects LLC	71,000	$0.20M	0.1%	+149.1%	0.016%
7/11/2023	Bard Financial Services Inc.	19,250	$54K	0.0%	N/A	0.004%
6/14/2023	State Board of Administration of Florida Retirement System	22,717	$41K	0.0%	-42.5%	0.005%
5/26/2023	Sheets Smith Wealth Management	1,590,398	$2.90M	0.4%	+3.0%	0.365%
5/26/2023	ProShare Advisors LLC	38,363	$70K	0.0%	-12.1%	0.009%
5/18/2023	JPMorgan Chase & Co.	1,613,297	$2.94M	0.0%	+5.2%	0.370%
5/18/2023	New York State Common Retirement Fund	33,705	$61K	0.0%	-42.6%	0.008%
5/16/2023	Apollon Wealth Management LLC	13,600	$25K	0.0%	N/A	0.003%
5/16/2023	State Street Corp	2,649,813	$4.82M	0.0%	-60.7%	0.608%
5/16/2023	Squarepoint Ops LLC	481,915	$0.88M	0.0%	N/A	0.111%
5/16/2023	First Trust Advisors LP	155,497	$0.28M	0.0%	+166.2%	0.036%
5/16/2023	Geode Capital Management LLC	1,945,864	$3.54M	0.0%	-4.2%	0.446%
5/16/2023	Armistice Capital LLC	5,795,927	$10.55M	0.2%	N/A	1.330%
5/16/2023	Balyasny Asset Management L.P.	72,266	$0.13M	0.0%	-91.9%	0.017%
5/15/2023	Schonfeld Strategic Advisors LLC	79,100	$0.14M	0.0%	-49.0%	0.018%
5/15/2023	Cubist Systematic Strategies LLC	152,355	$0.28M	0.0%	N/A	0.035%
5/15/2023	Deutsche Bank AG	56,249	$0.10M	0.0%	+35.9%	0.013%
5/15/2023	Price T Rowe Associates Inc. MD	166,758	$0.30M	0.0%	+11.2%	0.038%
5/15/2023	Sheets Smith Wealth Management	2	$2.90M	0.4%	-100.0%	0.000%
5/12/2023	BlackRock Inc.	6,965,519	$12.68M	0.0%	-0.8%	1.598%
5/12/2023	Bank of America Corp DE	174,526	$0.32M	0.0%	-76.8%	0.040%
5/12/2023	Inceptionr LLC	18,302	$33K	0.0%	N/A	0.004%
5/12/2023	HRT Financial LP	69,888	$0.13M	0.0%	N/A	0.016%
5/12/2023	UBS Group AG	114,378	$0.21M	0.0%	-69.0%	0.026%
5/12/2023	ProShare Advisors LLC	38,363	$70K	0.0%	-12.1%	0.009%
5/12/2023	Charles Schwab Investment Management Inc.	715,635	$1.30M	0.0%	-1.1%	0.164%
5/11/2023	Meitav Investment House Ltd.	43,429	$0.12M	0.0%	N/A	0.010%
5/10/2023	Clearwater Capital Advisors LLC	317,151	$0.58M	0.1%	+70.6%	0.073%
5/10/2023	Credit Suisse AG	889,699	$1.62M	0.0%	+29.0%	0.204%
5/10/2023	Pictet Asset Management SA	2,421,900	$4.41M	0.0%	+186.2%	0.556%
5/10/2023	Swiss National Bank	259,200	$0.47M	0.0%	-10.6%	0.059%
5/9/2023	Principal Financial Group Inc.	64,808	$0.12M	0.0%	-6.0%	0.015%
5/9/2023	Tower Research Capital LLC TRC	27,042	$49K	0.0%	+326.8%	0.006%
5/9/2023	Bank of New York Mellon Corp	440,333	$0.80M	0.0%	-2.1%	0.101%
5/9/2023	Fishman Jay A Ltd. MI	112,000	$0.20M	0.0%	+387.0%	0.026%
5/9/2023	Y Intercept Hong Kong Ltd	39,242	$71K	0.0%	N/A	0.009%
5/8/2023	New York Life Investment Management LLC	262,454	$0.48M	0.0%	N/A	0.060%
5/8/2023	Federated Hermes Inc.	22,007	$40K	0.0%	N/A	0.005%
5/5/2023	Pinnacle Associates Ltd.	107,775	$0.20M	0.0%	N/A	0.025%
5/4/2023	Pinnacle Wealth Management Advisory Group LLC	102,740	$0.19M	0.0%	N/A	0.024%

Data available starting January 2016

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases in the United States and Europe. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion protein N-803, vaccine technologies, toll-Like receptor activating adjuvants, natural killer cells, and damage-associated molecular patterns inducers. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute and Amyris, Inc.; and license agreements with LadRx Corporation, GlobeImmune, Inc., Access to Advanced Health Institute, 3M Innovative Properties Company, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company is based in San Diego, California.

Today's Range

Now: $3.43

$3.35

$3.54

50 Day Range

MA: $2.82

$1.26

$4.22

52 Week Range

Now: $3.43

$1.21

$7.10

Volume

2,498,706 shs

Average Volume

3,914,509 shs

Market Capitalization

$2.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of ImmunityBio?: ImmunityBio's top insider shareholders include:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More about top insider investors at ImmunityBio.
Who are the major institutional investors of ImmunityBio?: ImmunityBio's top institutional shareholders include:
Armistice Capital LLC — 0.76%
Northern Trust Corp — 0.25%
Charles Schwab Investment Management Inc. — 0.23%
Group One Trading L.P. — 0.00%
New York Life Investment Management LLC — 0.04%
Blair William & Co. IL — 0.04%
Learn More about top institutional investors of ImmunityBio stock.
Which institutional investors are selling ImmunityBio stock?: Within the last quarter, IBRX stock was sold by these institutional investors:
New York Life Investment Management LLC
Wealth Effects LLC
Wolverine Trading LLC
Barclays PLC
California State Teachers Retirement System
Northern Trust Corp
Rhumbline Advisers
Virtus ETF Advisers LLC
Which institutional investors are buying ImmunityBio stock?: During the previous quarter, IBRX stock was purchased by institutional investors including:
Armistice Capital LLC
Group One Trading L.P.
Blair William & Co. IL
Stonehage Fleming Financial Services Holdings Ltd
Rathbones Group PLC
Charles Schwab Investment Management Inc.
SG Americas Securities LLC
Vanguard Personalized Indexing Management LLC
In the last year, these company insiders have bought ImmunityBio stock:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More investors buying ImmunityBio stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

IBRX Insider Trading

ImmunityBio Insider Trading History Chart

ImmunityBio Share Price & Price History

ImmunityBio Insider Trading History

SEC Filings (Institutional Ownership Changes) for ImmunityBio (NASDAQ:IBRX)

Institutional Buying and Selling by Quarter

ImmunityBio Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of ImmunityBio?

Who are the major institutional investors of ImmunityBio?

Which institutional investors are selling ImmunityBio stock?

Which institutional investors are buying ImmunityBio stock?